Tel Aviv/Zurich, 4 August 2014 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY), a leading provider and developer of advanced personal telemedicine solutions, today announced results from a study on hospital readmission rates for patients who have suffered from acute myocardial infarction (AMI). The study, which was conducted by the Departments of Cardiology and Internal Medicine at Tel Aviv University, demonstrated that SHL Telemedicine subscribers who had been hospitalized for AMI within the past 30 days experienced a 5.8 percent hospital readmission rate.
For more information click here
For more information click here
